Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study

Maturitas

Volumn 83, Issue , 2016, Pages 40-44

  Palma, F ^a   Volpe, A ^a   Villa, P ^b   Cagnacci, A ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Genitourinary syndrome of menopause (GSM); Hormone therapy; Postmenopausal women; Vaginal atrophy; Vaginal therapy

Indexed keywords

ADULT; ARTICLE; BURN; CLINICAL EVALUATION; DYSPAREUNIA; DYSURIA; FEMALE; GENITOURINARY SYNDROME OF MENOPAUSE; GYNECOLOGICAL EXAMINATION; GYNECOLOGIST; HIGH RISK PATIENT; HUMAN; INVESTIGATIVE PROCEDURES; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; MUCOSAL DISEASE; MUCOSAL DRYNESS; MUCOSAL FRAGILITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PALLOR; PERCEPTION; PETECHIA; POSTMENOPAUSE; PREVALENCE; PRURITUS; SEDENTARY LIFESTYLE; SENSATION; UROGENITAL TRACT DISEASE; VAGINA ATROPHY; VAGINA PH; VAGINAL DRYNESS; VAGINITIS; VULVA DISEASE; VULVAR AND VAGINAL ATROPHY; AGED; ATROPHY; CLINICAL TRIAL; MIDDLE AGED; PATHOLOGY; RISK FACTOR; VAGINA; VAGINAL DISEASES; VULVA;

HORMONE;

AGED; ATROPHY; DYSPAREUNIA; FEMALE; HORMONES; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREVALENCE; RISK FACTORS; SEDENTARY LIFESTYLE; VAGINA; VAGINAL DISEASES; VULVA;

EID: 84951798879     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2015.09.001     Document Type: Article

References (27)

1. B. Mac, M.B. ride, D.J. Rhodes, and L.T. Shuster Vulvovaginal atrophy Mayo Clin. Proc. 85 2010 87 94
2. North American Menopause Society The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society Menopause 14 2007 355
3. D.J. Portman, and M.L. Gass Vulvovaginal atrophy terminology consensus conference panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society Maturitas 79 2014 349 354
4. S.J. Parish, R.E. Nappi, M.L. Krychman, and et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy Int. J. Women's Health 5 2013 437 447
5. US Census Bureau. Age and sex composition: 2010. 2011 May. Report No.: C2010BR-03.
6. O. Tan, K. Bradshaw, and B.R. Carr Management of vulvovaginal atrophy related sexual dysfunction in postmenopausal women: an up-to-date review Menopause 19 2012 109 117
7. North American Menopause Society Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society Menopause 20 2013 888 902
8. M. Bygdeman, and M.L. Swahn Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women Maturitas 23 1996 259 263
9. J.A. Van der Laak, L.M. de Bie, H. de Leeuw, and et al. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerized cytometry J. Clin. Pathol. 55 2002 446 451
10. Wyeth. REVEAL. Revealing vaginal effects at mid-Life. Surveys of postmenopausal women and health care professionals who treat postmenopausal women. Madison, NJ: Wyeth, 2009. Available from: < http://www.revealsurvey.com/pdf/reveal-survey-results.pdf />
11. R.E. Nappi, and M. Kokot-Kierepa Vaginal health insights, views & attitudes (VIVA) - results from an international survey Climacteric 15 2012 36 44
12. Pfizer Pharmaceuticals, Inc. Healthy women survey. Available at: < http://www.personalmenopauseanswers.com/healthywomen-survey.aspx /> (accessed 08.11.12).
13. S.A. Kingsberg, S. Wysocki, L. Magnus, and et al. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (Real Women's views of treatment options for menopausal vaginal changes) survey J. Sex Med. 10 2013 1790 1799
14. R.E. Nappi, S. Kingsberg, R. Maamari, and et al. The CLOSER (clarifying vaginal atrophy's impact on sex and relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners J. Sex Med. 10 2013 2232 2241
15. S. Roy, J.C. Caillouette, T. Roy, and J.S. Faden Vaginal pH is similar to follicle-stimulating hormone for menopause diagnosis Am. J. Obstet. Gynecol. 190 2004 1272 1277
16. A.E. Capewell, M.A. McIntyre, and R.A. Elton Postmenopausal atrophy in elderly women: is a vaginal smear necessary for diagnosis Age Ageing 21 1992 117 120
17. L. Pandit, and J.G. Ouslander Postmenopausal vaginal atrophy and anthropic vaginitis Am. J. Med. Sci. 314 1997 228 231
18. A. Cano, J. Estévez, R. Usandizaga, J.L. Gallo, and et al. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study Menopause 19 2012 1130 1139
19. S. Wysocki, S. Kingsberg, and M. Krychman Management of vaginal atrophy: implications from the REVIVE Survey Clin. Med. Insights Reprod. Health 8 2014 23 30
20. P.U.L. Cabral, A.C. Canário, M.H. Spyrides, and et al. Physical activity and sexual function in middle-aged women Rev. Assoc. Med. Bras. 60 2014 47 52
21. G.E. Mead, W. Morley, P. Campbell, and et al. Exercise for depression Cochrane Database Syst. Rev. 8 2009 CD004366
22. L. Miles Physical activity and health Nutr. Bull. 32 2007 314 363
23. P.C. Dinas, Y. Koutedakis, and A.D. Flouris Effects of exercise and physical activity on depression Ir. J. Med. Sci. 180 2011 319 325
24. A.J. Daley, H.J. Stokes-Lampard, and C. Macarthur Exercise to reduce vasomotor and other menopausal symptoms: a review Maturitas 63 2009 176 180
25. K.B. Levine, R.E. Williams, and K.E. Hartmann Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women Menopause 15 2008 661 666
26. C.A. McGahuey, A.J. Gelenberg, C.A. Laukes, and et al. The Arizona sexual experience scale (ASEX): reliability and validity J. Sex Marital Ther. 26 2000 25 40
27. J. Rust, L. Derogatis, C. Rodenberg, and et al. Development and validation of a new screening tool for hypoactive sexual desire disorder: the brief profile of female sexual function (B-PFSF) Gynecol. Endocrinol. 23 2007 638 644